bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2025.08.12.669603

Interactions between tick-borne encephalitis virus non-structural protein 1 and blood-brain barrier tight junction proteins: potential clues to strain-specific neuropathogenicity

Goonawardane, N.·Pun, J.·Chaopreecha, J.·Liburd, J.·Khalid, S.·Jones, I. M.·Tomlinson, J. H.
View original source ↗Export metadata ↓

Abstract

Tick-borne encephalitis virus (TBEV) invades the central nervous system (CNS) through strain-specific mechanisms that remain poorly understood. In mosquito-borne orthoflaviviruses such as dengue and yellow fever viruses, the non-structural protein 1 (NS1) has been shown to disrupt endothelial barrier integrity by targeting tight junction proteins (TJPs), thereby facilitating viral neuroinvasion. However, comparable mechanisms in TBEV remain largely unexplored. Here, we investigate the potential interaction of NS1 from high (Hypr)- and low (Vs)-pathogenicity TBEV strains to different blood-brain barrier (BBB) TJPs, using AlphaFold3 (AF3) multimer modelling and in vitro binding assays. We find that NS1 from the highly pathogenic strain exhibits higher predicted interactions with multiple TJPs, including two junctional adhesion molecules (JAM-A, JAM-B) and Claudin-10, which are critical component of the paracellular barrier. In contrast, low pathogenic strain Vs interaction was limited to JAM-A and Claudin-5. Experimental validation using recombinant NS1 proteins revealed strain-specific binding profiles: Hypr NS1 displayed high-affinity, saturable direct binding to immobilized JAM-A (KD = 0.271 {micro}g/mL), whereas Vs NS1 showed negligible interaction (KD = 0.000023 {micro}g/mL). No binding to ZO-1, a barrier scaffold lacking an extracellular domain, was observed for either strain. This differential interaction may be modulated by 22 specific amino acid substitutions localized to the Wing and {beta}-ladder domains, which distinguish the highly neurovirulent Hypr strain from the avirulent Vs strain. Notably, despite its weak JAM-A interaction, the Vs strain is associated with slow-progressing infections that can culminate in chronic neurological disease, highlighting the need for further investigation into noncanonical pathways of neuroinvasion. GraphicsO_ST_ABSA graphical illustration of low-and high-pathogenic TBEV mediated compromised blood-brain barrier (BBB)C_ST_ABSThe left panel illustrates the cellular architecture of the BBB, including pericytes, endothelial cells, astrocytes, and blood vessels. The central panel depicts an intact BBB with tight junction proteins (JAM-A, ZO-1, Claudin) maintaining barrier integrity. The right panel shows strain-specific pathogenesis, highlighting a direct interaction between NS1 from the highly pathogenic Hypr strain and JAM-A, which may contribute to differential neuroinvasive outcomes. The schematic was created using BioRender.com. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=78 SRC="FIGDIR/small/669603v1_ufig1.gif" ALT="Figure 1"> View larger version (22K): org.highwire.dtl.DTLVardef@3e03c2org.highwire.dtl.DTLVardef@168e8f8org.highwire.dtl.DTLVardef@9703f1org.highwire.dtl.DTLVardef@83e24a_HPS_FORMAT_FIGEXP M_FIG C_FIG

Explore related subjects

microbiologyPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Goonawardane, N., Pun, J., Chaopreecha, J., Liburd, J., Khalid, S., Jones, I. M., Tomlinson, J. H.. 2025-08-12. Interactions between tick-borne encephalitis virus non-structural protein 1 and blood-brain barrier tight junction proteins: potential clues to strain-specific neuropathogenicity. https://doi.org/10.1101/2025.08.12.669603

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗
bioRxiv2026

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗
bioRxiv2026

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗